Cargando…
Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
Autores principales: | Yang, Wei, Ge, Fusheng, Lu, Shuaibing, Shan, Zhiming, Peng, Liangqun, Chai, Junhui, Liu, Hongxing, Li, Baodong, Zhang, Zhandong, Huang, Jinxi, Hua, Yawei, Zhang, Yonglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892580/ https://www.ncbi.nlm.nih.gov/pubmed/35252283 http://dx.doi.org/10.3389/fmed.2022.862010 |
Ejemplares similares
-
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Yang, Wei, et al.
Publicado: (2021) -
Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis
por: Yang, Wei, et al.
Publicado: (2022) -
Various Kinds of Functional Digestive Tract Reconstruction Methods After Proximal Gastrectomy
por: Lu, Shuaibing, et al.
Publicado: (2021) -
Which is the optimal management for locally advanced gastric cancer patients with TRG 0 and 1 after R0 resection?
por: Ma, Fei, et al.
Publicado: (2020) -
PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS
por: Zhang, Zhandong, et al.
Publicado: (2023)